VSL Pharmaceuticals
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| PRObiotic VSL#3® for Maintenance of Clinical and Endoscopic REMission in Ulcerative Colitis (NCT03415711) | VSL Pharmaceuticals | 2017-04-28 |
| Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis (NCT00951548) | VSL Pharmaceuticals | 2006-10-01 |
| The Effect of a Probiotic on Hepatic Steatosis (NCT00099723) | VSL Pharmaceuticals | 2004-10-01 |
Track VSL Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.